Terpenes investigation in IBD is based on their safety, pharmacokinetics, and thanks to their ability to regulate inflammatory pathways involving interleukins IL-1β, IL-6, and IL-8, eicosanoids, and growth factors [79]. Here, IL6 is linked to inflammatory bowel disease.